PIAZZA, FABRIZIO

PIAZZA, FABRIZIO  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 97 (tempo di esecuzione: 0.028 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Microbiota-gut-brain axis dysregulation in Alzheimer’s disease and its modulation through probiotic supplementation 01 - Articolo su rivista 2026 Piazza, Fabrizio +
Advancing dementia care: a review of Italy's public health response within the WHO Global Action Plan and European strategies 01 - Articolo su rivista 2025 Fabrizio PiazzaGiulia Remoli +
Analytical Validation of a pre-Industrial Prototype Assay for Anti-Aβ Autoantibody ultrasensitive quantification in patients with CAA-ri and ARIA-E of Alzheimer’s disease Immunotherapy 02 - Intervento a convegno 2025 Lucia, DDGrisafi, EGuzzi, FAntolini, LBasso, GPiazza, F +
Anti-Amyloid Treatments: A Therapeutic Revolution, Ready for Europe 01 - Articolo su rivista 2025 Piazza F. +
Cerebrospinal Fluid Biomarkers Profiling in Cerebral Amyloid Angiopathy and Relationship With Disease Phenotypes 01 - Articolo su rivista 2025 Piazza, Fabrizio +
Clinical and Neuroradiological Manifestations of Cerebral Amyloid Angiopathy: A Closer Look into the Natural History of a Frequent Disease 01 - Articolo su rivista 2025 Piazza F. +
Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease 01 - Articolo su rivista 2025 Piazza, Fabrizio +
Diagnosis and management of cerebral amyloid angiopathy: a scientific statement from the International CAA Association and the World Stroke Organization 01 - Articolo su rivista 2025 Piazza, F +
Iatrogenic CAA-ri supported by ARIA-E, raised CSF anti-Aβ autoantibodies and sTREM2 after COVID-19 vaccination 02 - Intervento a convegno 2025 Grisafi ELucia DDGuzzi FPiazza F. +
Mass Spectrometry Imaging in the clinical setting: do pretty images hold diagnostic potential? 02 - Intervento a convegno 2025 Bindi, GPiazza, FL'Imperio, VPagni, FMagni, MSmith, A +
Monoclonal antibodies for early Alzheimer disease: a long road to discovery and marketing approval, a short timeline for health systems to organise services 01 - Articolo su rivista 2025 Bellelli GFerrarese CPiazza F +
Positron Emission Tomography in Cerebral Amyloid Angiopathy: A Scoping Review 01 - Articolo su rivista 2025 Piazza, F +
The efficacy of cognitive stimulation, cognitive training, and cognitive rehabilitation for people living with dementia: a systematic review and meta-analysis 01 - Articolo su rivista 2025 Piazza, F. +
Traumatic Brain Injury and Chronic Traumatic Encephalopathy: Not Only Trigger for Neurodegeneration but Also for Cerebral Amyloid Angiopathy? 01 - Articolo su rivista 2025 Piazza, F +
Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA), updates in 2022-2023. Cerebrovascular disease and the failure of elimination of Amyloid-β from the brain and retina with age and Alzheimer's disease: Opportunities for therapy 01 - Articolo su rivista 2024 Piazza, Fabrizio +
Progress in the Treatment of Alzheimer’s Disease Is Needed – Position Statement of European Alzheimer’s Disease Consortium (EADC) Investigators 01 - Articolo su rivista 2024 Piazza F. +
Spontaneous and iatrogenic ARIA: Mechanistic insights from CAA‐related inflammation 01 - Articolo su rivista 2024 Piazza, FabrizioLucia, Davide DonatoGuzzi, FrancescaDe Bernardi, ElisabettaAntolini, LauraBasso, Gianpaolo +
Spontaneous Non-Aneurysmal Convexity Subarachnoid Hemorrhage: A Scoping Review of Different Etiologies beyond Cerebral Amyloid Angiopathy 01 - Articolo su rivista 2024 Piazza F. +
The Italian guideline on diagnosis and treatment of dementia and mild cognitive impairment 01 - Articolo su rivista 2024 Fabrizio Piazza +
CAA-ri and ARIA: Two Faces of the Same Coin? 01 - Articolo su rivista 2023 Piazza, F. +